Frederick W. Immermann
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Hepatology top 10%
- Hepatitis C virus research
Papers in
-
- Bacterial biofilms and quorum sensing 1
-
- Antibiotics Pharmacokinetics and Efficacy 2
- Co-authors
- Patricia A. Bradford (2 shared papers)Alexey Ruzin (2 shared papers)Richard K. Koehn (1 shared paper)Jamie Lewis (1 shared paper)Indrasish Ray Chaudhuri (1 shared paper)Juliette O’Connell (1 shared paper)Donna N. Douglas (1 shared paper)Norman M. Kneteman (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (1 paper)Journal of Translational Medicine (1 paper)Biochemical Genetics (1 paper)Hepatology (1 paper)Vaccine (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Frederick W. Immermann
7 papers receiving 250 citations
Peers
Comparison fields: 5 of 51
- Molecular Medicine 81
- Hepatology 87
- Infectious Diseases 71
- Endocrinology 19
- Pollution 42
Countries citing papers authored by Frederick W. Immermann
This map shows the geographic impact of Frederick W. Immermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick W. Immermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick W. Immermann more than expected).
Fields of papers citing papers by Frederick W. Immermann
This network shows the impact of papers produced by Frederick W. Immermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick W. Immermann. The network helps show where Frederick W. Immermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Frederick W. Immermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 98 | |
| 2 | 2016 | 43 | |
| 3 | 2008 | 40 | |
| 4 | 2010 | 37 | |
| 5 | 1981 | 37 | |
| 6 | 1979 | 4 | |
| 7 | 2010 | 2 |
About Frederick W. Immermann
Frederick W. Immermann is a scholar working on Molecular Biology, Pharmacology, Molecular Medicine, Global and Planetary Change and Infectious Diseases, having authored 7 papers that have together received 261 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (2 papers), Antibiotic Resistance in Bacteria (2 papers), Antimicrobial Resistance in Staphylococcus (1 paper), Coral and Marine Ecosystems Studies (1 paper), Bacterial biofilms and quorum sensing (1 paper), Bacterial Genetics and Biotechnology (1 paper), Marine and fisheries research (1 paper) and Clostridium difficile and Clostridium perfringens research (1 paper). The work is most often cited by research in Molecular Medicine (81 citations), Hepatology (87 citations), Infectious Diseases (71 citations), Endocrinology (19 citations) and Pollution (42 citations). Frederick W. Immermann has collaborated with scholars based in United States and Canada. Frequent co-authors include Patricia A. Bradford, Alexey Ruzin, Richard K. Koehn, Jamie Lewis, Indrasish Ray Chaudhuri, Juliette O’Connell, Donna N. Douglas, Norman M. Kneteman, Stephen Villano and David F. Mercer. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Translational Medicine, Biochemical Genetics, Hepatology and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.